Tar Heel Times
Your comprehensive source for Tar Heel sports news

UNC ranked 7th among biomedical research institutions


Researchers at the University of North Carolina at Chapel Hill are using genetically engineered mouse models to help predict how humans will respond to different chemotherapy drug combinations used to fight breast cancer. Last year, UNC scientists identified biomarkers for challenging molecular subtypes of human breast cancer in genetically engineered mice, specifically looking for types that have few known targets and available therapies. (Fierce Biotech Research)


Share: Facebook | Twitter | Email

Related:

Recent Campus Connections News:

A Good Heart

UNC Startup Impact Totals $7 Billion in North Carolina

Remembering Chancellor William Aycock

After 45-Year Wait, James Taylor Earns First No. 1 Album on Billboard Chart

Fund Established to Honor Chapel Hill Shooting Victims


© 2005-2015 Tar Heel Times | Contact | Privacy Policy | Site Map | RSS | Did UNC Win?

Tar Heel Times is an unofficial resource for UNC fans and is not affiliated with the University of North Carolina.